ASHISH B PATEL

Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease PASADENA, CA NPI 1104023977

General Payments — all program years on this page

$6,725.65

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 314
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $640.36 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $446.6317
Education $180.191
Travel and Lodging $13.541

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Abbott Laboratories $180.191
GlaxoSmithKline, LLC. $176.429
Lilly USA, LLC $135.652
Mylan Specialty L.P. $59.213
Inspire Medical Systems, Inc. $50.302
OptiNose US, Inc. $20.001
Acerta Pharma LLC $18.591

By program year

Program yearAmountRecords
2018 $2,047.46103
2019 $1,817.05100
2020 $624.9134
2021 $649.1327
2022 $409.5520
2023 $537.1911
2024 $640.3619

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1105858394 AstraZeneca Pharmaceuticals LP $18.59 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115874009 GlaxoSmithKline, LLC. $23.39 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116137593 GlaxoSmithKline, LLC. $21.62 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116207407 GlaxoSmithKline, LLC. $18.56 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116346718 GlaxoSmithKline, LLC. $22.65 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116404625 GlaxoSmithKline, LLC. $22.30 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116522702 GlaxoSmithKline, LLC. $23.22 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116538842 GlaxoSmithKline, LLC. $21.62 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116654277 GlaxoSmithKline, LLC. $0.92 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116659261 GlaxoSmithKline, LLC. $22.14 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125388386 Abbott Laboratories $180.19 09/10/2024 Education Undisputed 01/23/2026 View at CMS
1136058880 Lilly USA, LLC $122.11 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136058882 Lilly USA, LLC $13.54 02/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1142182698 Optinose US, Inc. $20.00 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147291478 Mylan Specialty L.P. $20.11 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147295641 Mylan Specialty L.P. $16.67 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147325014 Mylan Specialty L.P. $22.43 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148093325 Inspire Medical Systems, Inc. $24.49 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148093329 Inspire Medical Systems, Inc. $25.81 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.